BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 31941257)

  • 1. [The guidelines of prevention and treatment for chronic hepatitis B (2019 version)].
    ;
    Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):938-961. PubMed ID: 31941257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.
    ;
    J Hepatol; 2017 Aug; 67(2):370-398. PubMed ID: 28427875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hepatitis B: who, when, and how?
    Wong SN; Lok AS
    Arch Intern Med; 2006 Jan; 166(1):9-12. PubMed ID: 16401805
    [No Abstract]   [Full Text] [Related]  

  • 4. Potential threat of drug-resistant and vaccine-escape HBV mutants to public health.
    Teo CG; Locarnini SA
    Antivir Ther; 2010; 15(3 Pt B):445-9. PubMed ID: 20516564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updated Hepatitis B Guidance: Implications for liver transplant patients.
    Verna EC
    Liver Transpl; 2018 Apr; 24(4):465-469. PubMed ID: 29466838
    [No Abstract]   [Full Text] [Related]  

  • 6. [Natural course and treatment guideline for chronic HBV infection].
    Akuta N
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():506-9. PubMed ID: 26845986
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic hepatitis B virus infection.
    Zoulim F
    Antiviral Res; 2004 Oct; 64(1):1-15. PubMed ID: 15451174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Highlights of the guidelines of prevention and treatment for chronic hepatitis B (2019 version)].
    Jia JD; Hou JL; Wei L; Zhuang H
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):21-23. PubMed ID: 32023693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2018 Korean Association for the Study of the Liver (KASL) Clinical Practice Guidelines of Chronic Hepatitis B: What's Different?
    Kim JH
    Korean J Gastroenterol; 2019 Mar; 73(3):132-140. PubMed ID: 31013556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative antiviral therapy for chronic hepatitis B-related hepatocellular carcinoma.
    Wei Q; Xu X; Ling Q; Zhou B; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):251-5. PubMed ID: 23742769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Guidelines for the prevention and treatment of chronic hepatitis B (version 2022)].
    ;
    Zhonghua Gan Zang Bing Za Zhi; 2022 Dec; 30(12):1309-1331. PubMed ID: 36891718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment in every detected virus replication. New guideline for therapy of hepatitis B publicized].
    MMW Fortschr Med; 2007 Jul; 149(29-30):61. PubMed ID: 17703695
    [No Abstract]   [Full Text] [Related]  

  • 13. Expanding indications for chronic hepatitis B treatment: Is it really desirable to treat everyone?
    Di Dato F; Iorio R
    World J Gastroenterol; 2024 May; 30(17):2294-2297. PubMed ID: 38813053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B.
    Fung J; Lai CL; Yuen MF
    Expert Rev Anti Infect Ther; 2010 Jun; 8(6):717-26. PubMed ID: 20521898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to overcome antiviral-resistant hepatitis B virus?
    Song BC
    Intervirology; 2010; 53(1):29-38. PubMed ID: 20068338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical characteristics of hepatic flare and efficacy of antiviral therapy in pregnant women with chronic hepatitis B virus infection].
    Ding Y; Sheng QJ; Zhang C; Wu YY; Yuan SY; Xia TT; An ZY; Dou XG
    Zhonghua Gan Zang Bing Za Zhi; 2019 Feb; 27(2):106-111. PubMed ID: 30818914
    [No Abstract]   [Full Text] [Related]  

  • 17. Viral breakthrough during lamivudine therapy for chronic hepatitis B.
    Leung N
    Intervirology; 2003; 46(6):344-9. PubMed ID: 14688450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic hepatitis B and viral genotype: the clinical significance of determining HBV genotypes.
    Guettouche T; Hnatyszyn HJ
    Antivir Ther; 2005; 10(5):593-604. PubMed ID: 16152753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HBV mutations during antiviral therapy in patients with chronic hepatitis B].
    Hwang SG
    Korean J Hepatol; 2005 Dec; 11(4):311-9. PubMed ID: 16380660
    [No Abstract]   [Full Text] [Related]  

  • 20. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States.
    Keeffe EB; Dieterich DT; Han SH; Jacobson IM; Martin P; Schiff ER; Tobias H; Wright TL
    Clin Gastroenterol Hepatol; 2004 Feb; 2(2):87-106. PubMed ID: 15017613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.